Latest Global Longlife Hospital & Research stock price
Global Longlife Hospital & Research P/E Ratio
GLHRL • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
114.47
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
114.47
Current Price
₹
EPS (TTM)
₹0.19
Exchange
None
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
55.64
Sector Median
45.1
Sector Rank
#11 of 44
Sector Percentile
25.0%
Key P/E Ratio Insights for Global Longlife Hospital & Research
- Stock appears overvalued with PE of 114.47, suggesting caution for new investments
- Trading at premium to sector average PE of 55.64
View the GLHRL equity price for detailed stock performance.
Related Pages for Global Longlife Hospital & Research
Additional stock information and data for GLHRL
Sector P/E Ratio Comparison
Comparing Global Longlife Hospital & Research with other companies in Healthcare Services sector
Sector Average
55.64
Sector Median
45.1
Lowest P/E
9.39
Highest P/E
369.22
Companies
44
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 9.39 | ₹150 | Low |
| NG Industries | NGIND | 10.6 | ₹51 | Low |
| Nidan Labs & Healthcare | NIDAN | 12.96 | ₹26 | Low |
| Shanmuga Hospital | SHANMUGA | 14.08 | ₹62 | Low |
| Medinova Diagnostic Serv… | MEDINOV | 20.28 | ₹44 | Moderate |
| Tejnaksh Healthcare | TEJNAKSH | 20.93 | ₹32 | Moderate |
| Indraprastha Medical Cor… | INDRAMEDCO | 22.89 | ₹4,013 | Moderate |
| One Global Service Provi… | ONEGLOBAL | 25.11 | ₹1,102 | High |
| Clinitech Laboratory | CTLLAB | 25.14 | ₹10 | High |
| Asarfi Hospital | ASARFI | 25.4 | ₹345 | High |